Covid-19 vaccines: India’s proposed WTO patent waiver faces stiff opposition from US, EU
Pfizer and its partner BioNTech have said their vaccine will cost $19.50 a dose in the USPremium
4 min read
Hugo Miller,
, Bloomberg
The WTO meeting of all 164 member states in Geneva last week ended without consensus, leaving poorer countries who sponsored the proposal frustrated and legal protections for vaccines intact
Share Via
Read Full Story
Covid-19 vaccines look set to protect millions of citizens of the world’s richest countries in the coming months. But inoculating the rest of the planet’s population may mean finding a way around an impasse over intellectual property.